mechanism 1,407 words KG: SASP
Contents

SASP (Senescence-Associated Secretory Phenotype) in Neurodegeneration

Mechanism Info
NameSASP
Key Genes/ProteinsCDKN2A, cxcl10, MTOR
Related DiseasesAlzheimer's Disease, Alzheimer'S Disease, Aβ-induced neurotoxicity, fibrosis, microglial senescence
Related PathwaysBDNF expression, MAPK
Linked Hypotheses40 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (149)

Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.70
Axonal RNA Transport Reconstitution
Score: 0.70
Mitochondrial Transfer Pathway Enhancement
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Ocular Immune Privilege Extension
Score: 0.69
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.69
Extracellular Matrix Stiffness Modulation
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.69
Cross-Seeding Prevention Strategy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
Lysosomal Positioning Dynamics Modulation
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Flotillin-1 Stabilization Compounds
Score: 0.68
R-Loop Resolution Enhancement Therapy
Score: 0.68
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
← Prevpg 4/8Next →

Related Analyses (30)

Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Vascular Contributions to Alzheimer Disease and Mixed Pathol
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.40
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40

See Also (15)

Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses

Knowledge Graph (12 edges)

SASP activates fibrosis
SASP activates neuroinflammation
Senescent Microglia associated_with SASP
SASP expressed_in Senescent Microglia
Senescent Microglia expressed_in SASP
SASP mediates chronic inflammation
senescent cells develops SASP
SASP promotes chronic inflammation
SASP promotes tissue dysfunction
NFKB1 promotes SASP

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.